Fate Therapeutics (FATE) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- S&P 500, Nasdaq advance as oil eases ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| FATE THERAPEUTICS (NASDAQ: FATE) | Delayed: 2.05 -0.01 (0.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.06 | 52 Week High | $4.76 | |||
| Open | $2.05 | 52 Week Low | $1.46 | |||
| Day High | $2.07 | P/E | N/A | |||
| Day Low | $2.03 | EPS | $-1.91 | |||
| Volume | 161,926 | |||||
